Personalized Oncology’s Regulatory Crossroads: Systemic Shifts in Precision Medicine Adoption
Personalized oncology is redefining the pharmaceutical value chain, prompting regulators to co‑approve drugs and diagnostics while reshaping talent hierarchies toward data‑centric expertise.










